指南与共识泌尿生殖腹部USMR

美国放射学会适宜性标准®:血精

ACR Appropriateness Criteria® Hematospermia.
指南 / 共识 · J Am Coll Radiol · 2017-01-01

美国放射学会适宜性标准®针对血精的影像检查选择给出推荐。多数年轻(<40岁)患者为短暂或发作性血精且自限,影像学不起作用;>40岁男性建议进行前列腺癌临床筛查。对持续或难治性血精或伴其他症状体征者,经直肠超声(TRUS)为首选影像,MRI用于TRUS不确定或阴性时。

要点

  • 多数<40岁男性血精为短暂或发作性且自限,影像学不起作用。
  • >40岁男性血精建议进行前列腺癌临床筛查。
  • 持续或难治性血精或伴其他症状体征者,TRUS为首选影像,MRI用于TRUS不确定或阴性时。

核心结论

  • 年轻(<40岁)男性短暂或发作性血精通常自限且为特发性,影像学不起作用;>40岁男性建议前列腺癌临床筛查;持续或难治性血精或伴其他症状体征者,TRUS为首选影像,MRI用于TRUS不确定或阴性时。

研究设计与样本

  • 美国放射学会适宜性标准,由多学科专家小组每年审查,基于同行评议期刊文献的广泛分析,采用RAND/UCLA适宜性方法和GRADE对特定临床场景的影像与治疗操作适宜性进行评级;证据缺乏或模棱两可时,专家意见可补充现有证据。

诊断标准与关键数值

  • 年轻(<40岁)男性短暂或发作性血精且无其他疾病症状体征时,影像学不起作用。
  • >40岁男性血精建议进行前列腺癌临床筛查。
  • 持续或难治性血精或伴其他症状体征者,TRUS为首选影像,MRI用于TRUS不确定或阴性时。
  • 可识别的病因包括泌尿生殖道感染、精阜水平梗阻或狭窄、前列腺/射精管/精囊钙化或结石,以及这些结构内的囊肿。

临床应用与阅片要点

  • 对<40岁短暂或发作性血精且无其他症状体征者,影像学不起作用。
  • 对>40岁血精男性,建议进行前列腺癌临床筛查。
  • 对任何年龄持续或难治性血精或伴其他症状体征者,TRUS为首选影像,MRI用于TRUS不确定或阴性时。

局限性

  • 证据缺乏或模棱两可时,专家意见可补充现有证据来推荐影像或治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Most men with hematospermia or hemospermia (HS) are young (<40 years of age), presenting with transient or episodic HS without other signs or symptoms of disease. The condition is self-limiting in most cases and idiopathic in nature. When a cause can be identified, infections of the urogenital tract are the most common. Imaging does not play a role in this patient population. In older men (>40 years of age), clinical screening for prostate cancer is advised. Furthermore, when HS is persistent or has symptoms, causes include obstruction or stricture at the level of the verumontanum, calcifications or calculi in the prostate, ejaculatory ducts or seminal vesicles, and cysts arising within these structures. Noninvasive imaging, predominantly transrectal ultrasound (TRUS) and MRI, can be used in men of any age with persistent or refractory HS, or other associated symptoms or signs. TRUS is considered as the first-line imaging with MRI used when TRUS is inconclusive or negative. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer-reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Hosseinzadeh K, Oto A, Allen BC, et al. ACR Appropriateness Criteria® Hematospermia. J Am Coll Radiol. 2017. PMID: 28473071. doi:10.1016/j.jacr.2017.02.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。